Journal of Animal Health and Production

Research Article
J. Anim. Health Prod. 9(s1): 77-83
 
Figure 1

HPLC chromatograms standard curve of cefepime. 

Figure 2

HPLC chromatograms of cefepime residual level in rabbit tissues in 1st day post I/M cefepime treatment. (A) cefepime residue in kidney, (B). cefepime residue in liver ,(C). cefepime residue in breast muscle. 

Figure 3

HPLC chromatograms of cefepime residual level in rabbit tissues on 3rd day post I/M cefepime treatment. (A) cefepime residue in kidney, (B). cefepime residue in liver ,(C). cefepime residue in breast muscle. 

Figure 4

HPLC chromatograms of cefepime residual level in rabbit tissues at 7th day post I/M cefepime treatment. (A) cefepime residue in kidney, (B). cefepime residue in liver, (C). cefepime residue in breast muscle.  

Figure 5

HPLC chromatograms of cefepime residual level in rabbit tissues at 14th day post I/M cefepime treatment. (A) cefepime residue in kidney, (B). cefepime residue in liver. 

Figure 6

Effect of cefepime on serum AST, ALT and ALP concentration (U/L) on 1st,3rd,7th and 14th days post treatment. (A) AST(U/L), (B) ALT (U/L), (C) ALP(U/L).
 

Figure 7

Effect of cefepime on serum total protein and albumin concentration (g/dl) on 1st, 3rd, 7th and 14th day post treatment. (A) Total protein (g/dl), (B) Albumin (g/dl). 

Figure 8

Effect of cefepime on urea and creatinine concentration (g/dl) on 1st, 3rd,7th and 14th day post treatment. (A) urea (mg/dl), (B) creatinine (mg/dl).